CAD 0.06
(-7.69%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 69 Thousand CAD | 102.94% |
2022 | 34 Thousand CAD | -66.99% |
2021 | 103 Thousand CAD | -99.04% |
2020 | 10.76 Million CAD | 22.88% |
2019 | 8.75 Million CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 58 Thousand CAD | 0.0% |
2024 Q2 | 47 Thousand CAD | 0.0% |
2023 Q4 | 69 Thousand CAD | -12.66% |
2023 FY | 69 Thousand CAD | 102.94% |
2023 Q2 | 1.82 Million CAD | 10055.56% |
2023 Q1 | 18 Thousand CAD | -47.06% |
2023 Q3 | 79 Thousand CAD | -95.68% |
2022 Q2 | 70 Thousand CAD | -19.54% |
2022 Q4 | 34 Thousand CAD | -32.0% |
2022 FY | 34 Thousand CAD | -66.99% |
2022 Q1 | 87 Thousand CAD | -15.53% |
2022 Q3 | 50 Thousand CAD | -28.57% |
2021 Q1 | 148 Thousand CAD | -98.62% |
2021 FY | 103 Thousand CAD | -99.04% |
2021 Q4 | 103 Thousand CAD | -2.83% |
2021 Q3 | 106 Thousand CAD | 15.22% |
2021 Q2 | 92 Thousand CAD | -37.84% |
2020 FY | 10.76 Million CAD | 22.88% |
2020 Q1 | 553 Thousand CAD | -93.69% |
2020 Q2 | 14.66 Million CAD | 2551.18% |
2020 Q3 | 23.64 Million CAD | 61.3% |
2020 Q4 | 10.76 Million CAD | -54.5% |
2019 Q2 | - CAD | 0.0% |
2019 FY | 8.75 Million CAD | 0.0% |
2019 Q4 | 8.75 Million CAD | 1709.3% |
2019 Q3 | 484 Thousand CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aurora Cannabis Inc. | 47.57 Million CAD | 99.855% |
Avicanna Inc. | 95.36 Thousand CAD | 27.644% |
Avant Brands Inc. | 1.74 Million CAD | 96.037% |
Cardiol Therapeutics Inc. | 158.53 Thousand CAD | 56.476% |
Crescita Therapeutics Inc. | 815 Thousand CAD | 91.534% |
Knight Therapeutics Inc. | 44.01 Million CAD | 99.843% |
OrganiGram Holdings Inc. | 79 Thousand CAD | 12.658% |
Canopy Growth Corporation | 493.29 Million CAD | 99.986% |
Willow Biosciences Inc. | 594 Thousand CAD | 88.384% |
Auxly Cannabis Group Inc. | 81.38 Million CAD | 99.915% |